M&A Deal Summary

PharmaLegacy Acquires BTS Research

On September 16, 2024, PharmaLegacy acquired life science company BTS Research

Acquisition Highlights
  • This is PharmaLegacy’s 1st transaction in the Life Science sector.
  • This is PharmaLegacy’s 1st transaction in the United States.
  • This is PharmaLegacy’s 1st transaction in California.

M&A Deal Summary
Date 2024-09-16
Target BTS Research
Sector Life Science
Buyer(s) PharmaLegacy
Deal Type Add-on Acquisition

Target

BTS Research

San Diego, California, United States
BTS Research is a Contract Research Organization that delivers GLP and non-GLP biological services to clients in pharmaceutical, biopharmaceutical, biotech, academic research, medical device, and related industries. BTS Research was formed in 2001 and is based in San Diego, California.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

PharmaLegacy

Shanghai, China
Category Company
Founded 2008
Sector Life Science
DESCRIPTION

PharmaLegacy is a CRO that provides efficient and cost-effective preclinical in vitro and in vivo pharmacology studies to life science organizations. PharmaLegacy was formed in 2008 and is headquartered in Shanghai, China.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2024) 1 of 1
Mergr

Product

Company

Legal